Skip to main content
Home
Home

  • People
  • Events
    AIHC New
    Science and Technology Policy
    Tue, Sep. 15 - Thu, Sep. 17, 2026 | 8 am - 6 pm
    AI in Health Conference See Details
    SynBio-Crop
    Science and Technology Policy
    Fri, Sep. 18, 2026 | 9 am - 5 pm
    Synthetic Biology at the Intersection of Science, Ethics, and Policy See Details
    Ellen Ochoa Image
    Science and Technology Policy
    Mon, Nov. 02, 2026 | 5:30 pm - 7:30 pm
    Joni Sue Lane Lecture Series — Exploring Space: A Conversation With Astronaut Ellen Ochoa See Details
  • Podcasts
  • Research Programs
  • Research & Commentary
  • Press
  • Support
  • About
  • Newsletter
  • Search
  • Research
  • Twitter
  • Facebook
  • instagram
  • Linkedin
  • Youtube
  • Newsletter
  • Economics & Finance
  • Energy
  • Foreign Policy
  • Domestic Policy
  • Health & Science
  • All Publications
Drug Policy | Report

Rx for U.S. Drug Policy: A New Paradigm

June 30, 2015 | William Martin, Jerry Epstein
RX Medicine

Table of Contents

Author(s)

William Martin

Nonresident Fellow in Religion and Public Policy | Director, Drug Policy Program

Jerry Epstein

Contributing Expert, Drug Policy Program

Share this Publication

  • Facebook
  • Twitter
  • Email
  • Linkedin
  • Download PDF
  • Print This Publication

Tags

Baker InstituteUnited StatesImproving drug policyDrug reform

To access the full paper, download the PDF on the left-hand sidebar.

No sensible person doubts that drugs can cause enormous harm. They can ruin lives. They are implicated in a wide range of crimes, and they enrich criminals. Drug trafficking fosters extraordinary brutality, endangers innocent citizens, and undercuts the development and practice of democracy by corrupting public officials in numerous countries, including the United States. That said, there remains considerable disagreement over the nature and extent of drug-related harm, the factors that contribute to its many facets, and the best ways to go about addressing the numerous issues that cluster together under the canopy of “the drug problem.”

For more than a century, beginning with the passing of the Harrison Narcotic Act in 1914, U.S. drug policy has been based on the concept of prohibition, on the desire for a “drug-free America” with “zero tolerance” for drug users, producers, and traffickers. For the last 40 years, it has been known as the War on Drugs. It is truly a war, with all the hallmarks of war: displaced populations, disrupted economies, excessive violence, terrorism, the use of military force, the curtailment of civil liberties, and the demonizing of enemies. And like other wars we have been engaged in over this same period, victory has been elusive.

In the Baker Institute’s Drug Policy Program, we are convinced that U.S. drug policy, as presently designed, is premised on incorrect assumptions, aimed at the wrong targets, and too often unresponsive to human needs and aspirations. Unfortunately, that is not a new insight. In fact, apart from the reference to the Baker Institute, that sentence is a verbatim quote from the 1973 report of the National Commission on Marihuana and Drug Abuse, appointed by President Richard Nixon, led by former Republican governor of Pennsylvania Raymond P. Shafer, and comprising a blue-ribbon panel of establishment figures chosen mostly by Nixon himself.

On June 17, 1971, Nixon announced that his administration was about to launch a “total war against Public Enemy Number One in the United States—the problem of dangerous drugs.” He did not use the words “War on Drugs,” but he characterized the effort as “a new, all-out offensive.” In a taped conversation with his chief of staff H.R. Haldeman in May, he had said, “I want a goddamn strong statement on marijuana … I mean one on marijuana that just tears the ass out of them. By God, we are going to hit the marijuana thing, and I want to hit it right square in the puss … against legalizing and all that sort of thing.”

Nixon’s plan was foiled by facts. In March 1972, the commission issued a preliminary report, Marihuana, A Signal of Misunderstanding, which declared that “neither the marihuana user nor the drug itself can be said to constitute a danger to public safety” and recommended that Congress and state legislatures decriminalize the use and casual distribution of marijuana and seek means other than prohibition to discourage use. Endorsers of these recommendations included the American Medical Association, the American Bar Association, the American Association for Public Health, the National Education Association, and the National Council of Churches.

Nixon angrily rejected the report and Congress declined to consider its recommendations, but the Shafer Commission pressed on and a year later ISSN 1941-6466 2 issued a second, more comprehensive report, Drug Use in America: Problem in Perspective. Nixon also ignored that one, declaring his intention to ratchet up his “attack on all fronts” in an “all-out war,” and “just kick the hell out of it.” He proposed and Congress approved the creation of the Drug Enforcement Administration (DEA), which merged existing anti-drug agencies into a single federal agency charged with coordinating government drug control actions. Forty years later, the DEA is one of the largest and most powerful agencies in the government, with a worldwide reach.

Since 1973, federal, state, and local governments have spent an estimated $1 trillion on eradication, interdiction, and incarceration. They have destroyed thousands of acres of crops, seized countless tons of contraband, and imprisoned more people than any other country in the world, a disproportionate number of them poor and black. Despite these efforts, illicit drugs continue to be available to meet a remarkably stable demand. As the Shafer Commission observed, “Drug policy can be thus summed up: increased use of disapproved drugs precipitates more spending, more programs, more arrests, and more penalties, all with little positive effect in reducing use of these drugs.”

Because that same statement holds true 40 years later, the NAACP, the US Conference of Mayors, the Latin American and Global Commissions on Drugs and Democracy, the Organization of American States, a growing number of influential think tanks and advocacy groups, and more than 80 percent of Americans regard the War on Drugs as a failure. Still, a century of anti-drug propaganda has shaped a set of convictions that serve as formidable barriers to sensible, humane drug policy, despite clear evidence that the propaganda is fraudulent. Current U.S. drug policy can never succeed. We need a new paradigm. Fortunately, we have the material to construct one.

After its surveys revealed a marked disjunction between public perception and empirical reality, the Shafer Commission urged federal and other levels of government to “maintain and monitor an ongoing collection of data necessary for present and prospective policy planning, including data on incidence, nature, and consequences of drug use.” That recommendation has been well satisfied. Monitoring the Future (MTF), begun in 1975, questions approximately 50,000 teens annually, with follow-ups in later years. The National Survey on Drug Use and Health (NSDUH)6 interviews approximately 70,000 people 12 years and older annually. These surveys, which qualify as big data, provide a rich and revealing picture of drug use in America and are consistently confirmed by other surveys. Still, although the information is available to anyone with a computer, few people appear to know the size or actual contours of drug use in this country, and the data play only a small role in public policy, mass media presentations, and popular perception.

 

 

This material may be quoted or reproduced without prior permission, provided appropriate credit is given to the author and Rice University’s Baker Institute for Public Policy. The views expressed herein are those of the individual author(s), and do not necessarily represent the views of Rice University’s Baker Institute for Public Policy.

  • Print This Publication
  • Share
    • Facebook
    • Twitter
    • Email
    • Linkedin

Related Research

Cannabis cultivation workers trimming hemp plants.
Center for Health Policy | Drug Policy | Policy Brief

How US Hemp Policy Can Balance Consumer Access and Public Health

Read More
Macro close up of droplet dosing a biological and ecological hemp
Texas Briefing | Drug Policy | Podcast

New Texas Hemp Rules and the Future of Cannabis Policy

Read More
Prescription opioid medication pills spilled onto table
Drug Policy | Press Release

Drug policy expert available to speak about fentanyl executive order

Read More
  • Contact Us
  • Donate Now
  • Press
  • Membership
  • Careers
  • Student Opportunities
  • About the Institute
  • Rice.edu

6100 Main Street
Baker Hall MS-40, Suite 120
Houston, TX 77005

Email: [email protected]
Phone: 713-348-4683
Fax: 713-348-5993

  • Twitter
  • Facebook
  • instagram
  • Linkedin
  • Youtube
  • Newsletter
  • © Rice University's Baker Institute for Public Policy
  • Web Accessibility
  • Privacy Policy